Background The relation between lower respiratory tract illnesses in early life caused by the
respiratory syncytial virus (RSV) and the subsequent development of wheezing and atopy in …

Background Whether vaccination during pregnancy could reduce the burden of respiratory
syncytial virus (RSV)–associated lower respiratory tract illness in newborns and infants is …

Rationale: Atopic sensitization has long been known to be related to asthma in children, but
its role in determining asthma prevalence remains to be elucidated further. Objectives: To …

The global burden of disease caused by respiratory syncytial virus (RSV) is increasingly
recognised, not only in infants, but also in older adults (aged ≥65 years). Advances in …

BACKGROUND: There is increasing evidence that wheezing during childhood may be a
heterogeneous condition, and that different forms of wheezing may be associated with different …

Asthma is a heterogenous disease with variable signs and symptoms among patients. It
also presents significant individual variability over time. Recently, some important population-…

Background: Respiratory syncytial virus (RSV) is a major public health burden worldwide.
We aimed to review the current literature on the incidence and mortality of severe RSV in …

Background Eczema, rhinitis, and asthma often coexist (comorbidity) in children, but the
proportion of comorbidity not attributable to either chance or the role of IgE sensitisation is …

Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory infections in
children. By the age of 1 year, 60%–70% of children have been infected by RSV. In addition…

Severe respiratory syncytial virus (RSV) infection is a major cause of morbidity and mortality
in infants <2 years-old. Here we describe that high-fiber diet protects mice from RSV infection…